<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We analyzed the expression pattern of <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecules including beta 1-integrins (CD49c, CD49d, CD49e, CD49f), beta 2-integrins (CD11a, CD11b, CD11c), CD44, and CD54 in 141 children with B-cell precursor <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> (<z:e sem="disease" ids="C1292769" disease_type="Neoplastic Process" abbrv="">pre-B ALL</z:e>) and in 21 children with B-cell ALL/non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">B-ALL</z:e>/NHL) </plain></SENT>
<SENT sid="1" pm="."><plain>The frequencies of CD11a, CD49f, and CD44 expression were significantly higher in CD34+ <z:e sem="disease" ids="C1292769" disease_type="Neoplastic Process" abbrv="">pre-B ALL</z:e> than in CD34- <z:e sem="disease" ids="C1292769" disease_type="Neoplastic Process" abbrv="">pre-B ALL</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Although CD49d, CD49e, and CD44 were less frequently expressed in <z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">B-ALL</z:e>/NHL than in <z:e sem="disease" ids="C1292769" disease_type="Neoplastic Process" abbrv="">pre-B ALL</z:e>, the expression of CD11a and CD54 were more frequent in <z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">B-ALL</z:e>/NHL </plain></SENT>
<SENT sid="3" pm="."><plain>In <z:e sem="disease" ids="C1292769" disease_type="Neoplastic Process" abbrv="">pre-B ALL</z:e>, expression of CD11a positively correlated with that of CD11b (P &lt; .05) and CD54 (P &lt; .01), and CD49c positively correlated with CD49f (P &lt; .01) </plain></SENT>
<SENT sid="4" pm="."><plain>Of the clinical parameters of patients with <z:e sem="disease" ids="C1292769" disease_type="Neoplastic Process" abbrv="">pre-B ALL</z:e>, expression of CD11a was associated with a low leukocyte count (P &lt; .05) </plain></SENT>
<SENT sid="5" pm="."><plain>The presence of CD54 on the cell surface was an independent factor indicating a poor prognosis </plain></SENT>
<SENT sid="6" pm="."><plain>The estimated 5-year event-free survival was 42.3% for CD54+ (n = 31) compared with 70.3% for CD54- patients (n = 38) (P &lt; .05) </plain></SENT>
<SENT sid="7" pm="."><plain>These findings demonstrated that expression of <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecules is dependent on the phenotype of B-lineage cells and that the expression of some of these molecules has clinical significance </plain></SENT>
</text></document>